...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning.
【24h】

Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning.

机译:用剂量乘积乘以器官剂量估算CT的有效剂量:采用国际放射防护委员会出版物103或双能扫描的结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The objective of our study was to compare dose-length product (DLP)-based estimates of effective dose with organ dose-based calculations using tissue-weighting factors from publication 103 of the International Commission on Radiological Protection (ICRP) or dual-energy CT protocols. MATERIALS AND METHODS: Using scanner- and energy-dependent organ dose coefficients, we calculated effective doses for CT examinations of the head, chest, coronary arteries, liver, and abdomen and pelvis using routine clinical single- or dual-energy protocols and tissue-weighting factors published in 1991 in ICRP publication 60 and in 2007 in ICRP publication 103. Effective doses were also generated from the respective DLPs using published conversion coefficients that depend only on body region. For each examination type, the same volume CT dose index was used for single- and dual-energy scans. RESULTS: Effective doses calculated for CT examinations using organ dose estimates and ICRP 103 tissue-weighting factors differed relative to ICRP 60 values by -39% (-0.5 mSv, head), 14% (1 mSv, chest), 36% (4 mSv, coronary artery), 4% (0.6 mSv, liver), and -7% (-1 mSv, abdomen and pelvis). DLP-based estimates of effective dose, which were derived using ICRP 60-based conversion coefficients, were less than organ dose-based estimates for ICRP 60 by 4% (head), 23% (chest), 37% (coronary artery), 12% (liver), and 19% (abdomen and pelvis) and for ICRP 103 by -34% (head), 37% (chest), 74% (coronary artery), 16% (liver), and 12% (abdomen and pelvis). All results were energy independent. CONCLUSION: These differences in estimates of effective dose suggest the need to reassess DLP to E conversion coefficients when adopting ICRP 103, particularly for scans over the breast. For the evaluated scanner, DLP to E conversion coefficients were energy independent, but ICRP 60-based conversion coefficients underestimated effective dose relative to organ dose-based calculations.
机译:目的:我们研究的目的是使用国际放射防护委员会(ICRP)第103号出版物或双重放射疗法的组织加权因子,将基于剂量长度乘积(DLP)的有效剂量估算与基于器官剂量的计算进行比较。能量CT协议。材料与方法:使用扫描仪和能量依赖的器官剂量系数,我们使用常规临床单能量或双能量方案和组织-剂量计算了头部,胸部,冠状动脉,肝脏,腹部和骨盆的CT检查的有效剂量。加权因子分别于1991年在ICRP出版物60和2007年在ICRP出版物103中发表。有效剂量也使用仅依赖于身体部位的公开转换系数从各个DLP中产生。对于每种检查类型,单能量和双能量扫描均使用相同体积的CT剂量指数。结果:使用器官剂量估计值和ICRP 103组织加权因子为CT检查计算的有效剂量相对于ICRP 60值相差-39%(-0.5 mSv,头部),14%(1 mSv,胸部),36%(4 mSv,冠状动脉),4%(0.6 mSv,肝脏)和-7%(-1 mSv,腹部和骨盆)。使用基于ICRP 60的转换系数得出的基于DLP的有效剂量估算值比针对ICRP 60的基于器官剂量的估算值低4%(头部),23%(胸部),37%(冠状动脉), ICRP 103分别为-34%(头部),37%(胸部),74%(冠状动脉),16%(肝脏)和12%(腹部)分别为12%(肝脏)和19%(腹部和骨盆),和骨盆)。所有结果均与能量无关。结论:有效剂量估算值的这些差异表明,采用ICRP 103时,尤其是对乳房进行扫描时,需要重新评估DLP到E的转换系数。对于经过评估的扫描仪,DLP到E的转换系数与能量无关,但是基于ICRP 60的转换系数相对于基于器官剂量的计算低估了有效剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号